| G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy MS Alghamri, BL McClellan, RP Avvari, R Thalla, S Carney, CS Hartlage, ... Science Advances 7 (40), eabh3243, 2021 | 57 | 2021 |
| Systemic delivery of an adjuvant CXCR4–CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy MS Alghamri, K Banerjee, AA Mujeeb, A Mauser, A Taher, R Thalla, ... ACS nano 16 (6), 8729-8750, 2022 | 55 | 2022 |
| Targeting neuroinflammation in brain cancer: uncovering mechanisms, pharmacological targets, and neuropharmaceutical developments MS Alghamri, BL McClellan, MS Hartlage, S Haase, SM Faisal, R Thalla, ... Frontiers in Pharmacology 12, 680021, 2021 | 51 | 2021 |
| Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1 MS Alghamri, R Thalla, RP Avvari, A Dabaja, A Taher, L Zhao, PJ Ulintz, ... Neuro-oncology Advances 2 (1), vdaa042, 2020 | 21 | 2020 |
| G-CSF Secreted by Epigenetically Reprogrammed Mutant IDH1 Glioma Stem Cells Reverses the Myeloid Cells’-Mediated Immunosuppressive Tumor Microenvironment MS Alghamri, RP Avvari, R Thalla, N Kamran, L Zhang, M Ventosa, ... BioRxiv, 2020.07. 22.215954, 2020 | 3 | 2020 |
| Murine brain tumor microenvironment immunophenotyping using mass cytometry BL McClellan, MS Alghamri, R Thalla, PR Lowenstein, MG Castro STAR protocols 3 (2), 101357, 2022 | 1 | 2022 |
| Systemic delivery of a CXCR4-CXCL12 signaling inhibitor encapsulated in synthetic protein nanoparticles for glioma immunotherapy MS Alghamri, K Banerjee, AA Mujeeb, A Taher, R Thalla, BL McClellan, ... bioRxiv, 2021.08. 27.457953, 2021 | 1 | 2021 |
| Active STAT3 Prevents Selinexor-Induced Caspase-Independent Apoptosis in Multiple Myeloma RM Mack, M Sellin, S Berg, R Thalla, K Joshi, L Zhang, S Liu, P Breslin, ... Blood 142, 6611, 2023 | | 2023 |
| Neuro-Oncology Advances MS Alghamri, R Thalla, RP Avvari, A Dabaja, A Taher, L Zhao, PJ Ulintz, ... | | 2020 |
| TUMOR MUTATIONAL BURDEN PREDICTS SURVIVAL IN PATIENTS WITH LOW GRADE GLIOMAS EXPRESSING MUTATED IDH1 SA Mahmoud, R Thalla, R Avvari, A Dabaja, A Taher, L Zhao, MG Castro, ... | | |
